Contingency Management Innovations wins New Mexico opioid treatment contract

By AI, Created 6:35 PM UTC, May 19, 2026, /AGP/ – Contingency Management Innovations has won a University of New Mexico contract to deploy its AI-enabled contingency management platform using New Mexico State Opioid Response funding. The deal is meant to expand evidence-based addiction treatment, improve engagement, and give other states a model for spending opioid recovery dollars.

Why it matters: - New Mexico is using federal opioid recovery funding to expand evidence-based addiction treatment through technology. - The contract could help improve treatment engagement, program completion, and recovery outcomes for people with stimulant and opioid use disorders. - The project may serve as a blueprint for other states weighing how to spend State Opioid Response grants and opioid settlement dollars.

What happened: - Contingency Management Innovations announced it was awarded a contract with the University of New Mexico to deploy its AI-enabled contingency management platform. - The initiative is funded through New Mexico’s State Opioid Response grant. - The effort is led by Dr. Kimberly Page, professor in the Department of Internal Medicine at UNM and principal investigator of the NIDA-funded Southwest Clinical Trials Network node at UNM. - The company framed the deal as a national model for translating opioid recovery funding into measurable treatment gains.

The details: - Contingency management is a behavioral intervention that uses structured positive reinforcement and real-time behavioral monitoring. - The approach is backed by decades of clinical research and is endorsed by SAMHSA. - The platform is designed to let UNM’s research and clinical team deliver personalized incentives, track participant engagement, and produce outcome data required by SOR funders. - The system is built on NIH-backed behavioral science and is designed to fit existing treatment and case management workflows. - New Mexico’s use of SOR funds for contingency management is presented as a replicable model for other states. - The platform also provides infrastructure, participant tracking, compliance reporting, and outcome data for scaling contingency management. - The initiative aligns with federal guidance from SAMHSA, CDC, and NIDA, which emphasize evidence-based and data-driven responses to the opioid crisis.

Between the lines: - The contract reflects a broader push to move opioid response dollars toward interventions with strong clinical evidence rather than unproven tools. - Contingency management has shown effectiveness in keeping people in treatment, but implementation barriers have limited wider adoption. - Technology is being positioned as the main way to make the intervention easier to deploy at scale. - Dr. Kimberly Page said the initiative is an important step in translating contingency management research into real-world practice and expanding access in underserved communities across New Mexico. - Steven Jenkins, CEO of Q2i, CMI’s parent company, said New Mexico is showing how SOR funds can support evidence-based, technology-enabled interventions and urged other states to consider contingency management a priority use of opioid response money.

What’s next: - UNM and CMI are expected to use the platform to support treatment delivery, engagement monitoring, and reporting under the SOR grant. - The program could influence how other states structure opioid recovery spending if New Mexico’s results show measurable gains. - CMI plans to continue marketing its platform for treatment programs, community supervision, and harm-reduction settings.

The bottom line: - New Mexico is betting that digital contingency management can turn opioid response funding into better treatment access and stronger outcomes.